Educational visual for Vallexa Advisors explaining hospice valuation multiples and the main factors that increase or reduce an EBITDA multiple, including compliance risk, normalized EBITDA, and referral concentration.
Related Articles
Key Drivers of Hospice Valuation Multiples in 2026
January 14, 2026
A Hospice Owner’s Guide to Valuation Multiples: How to Avoid Exit Pitfalls
December 30, 2025
Hospice Multiples in the Current Market
December 30, 2025